Literature DB >> 30259406

Dexmedetomidine Relieves Acute Inflammatory Visceral Pain in Rats through the ERK Pathway, Toll-Like Receptor Signaling, and TRPV1 Channel.

Yatao Liu1, Wei Liu2, Xiaoqing Wang1, Zhanhai Wan1, Yongqiang Liu1, Yufang Leng3.   

Abstract

Dexmedetomidine (DEX) is a highly selective α2 adrenergic receptor agonist. In this study, we aimed to characterize the antinociceptive effects of DEX in acute inflammatory visceral pain (AIVP) induced by acetic acid in rats and to evaluate whether antinociception was regulated by the extracellular signal-regulated protein kinase (ERK) pathway, Toll-like receptor (TLR) signaling, and transient receptor potential (TRP) channel. Acetic acid was administered to 30 male rats with or without DEX. Rats were divided into six groups, as follows: control, disease (received no treatment before acetic acid administration), vehicle-treated, low-dose DEX (lDEX), medium-dose DEX (mDEX), and high-dose DEX (hDEX)-treated groups. Thermal withdrawal latency (TWL), mechanical withdrawal threshold (MWT), and abdominal withdrawal reflex (AWR) were measured to assess pain. We detected electromyographic (EGM) responses in the rectus abdominis muscle and measured the average arterial blood pressure. Levels of interleukin 1 (IL-1), IL-2, and IL-6 in the serum, as well as tumor necrosis factor α (TNF-α) and prostaglandin E2 (PGE2) in the peritoneal fluid, were measured by ELISA. The expression levels of phospho(p)CREB, pERK1/2, pMEK1, and TRP cation channel subfamily V member 1 (TRPV1), as well as the activation state of TLR4, were determined in the spinal cord of rats by real-time polymerase chain reaction and western blot analysis. TWL and MWT scores were elevated (P < 0.05) in the hDEX and mDEX groups, whereas AWR scores decreased (P < 0.01), compared to those in the disease group. The medium and high doses of DEX suppressed IL-1, IL-6, TNF-α, and PGE2 release, and increased IL-2 release. In addition, protein and mRNA levels of MEK, ERK, and CREB were reduced in the mDEX and hDEX groups. Moreover, TLR4 and its downstream target, nuclear factor kappa B, along with calcitonin gene-related peptide release through the TRPV1 channel, were suppressed by mDEX and hDEX treatment. Taken together, our results suggest that DEX might exert an antinociceptive effect in AIVP in rats through the MEK/ERK pathway, TLR signaling, and TRPV1 channel, resulting in suppression of visceral hypersensitivity.

Entities:  

Keywords:  Acute inflammatory visceral pain; Dexmedetomidine; MEK/ERK signaling pathway; TRPV1 channel; Toll-like receptor

Mesh:

Substances:

Year:  2018        PMID: 30259406     DOI: 10.1007/s12031-018-1172-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  47 in total

1.  Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice.

Authors:  F Karim; C C Wang; R W Gereau
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons.

Authors:  A Diogenes; C C R Ferraz; A N Akopian; M A Henry; K M Hargreaves
Journal:  J Dent Res       Date:  2011-03-10       Impact factor: 6.116

3.  Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor.

Authors:  Hong Zhang; Xiang Yan; De-Gui Wang; Yu-Fang Leng; Zhan-Hai Wan; Yong-Qiang Liu; Yan Zhang
Journal:  Biomed Pharmacother       Date:  2017-04-22       Impact factor: 6.529

4.  Encoding of visceral noxious stimuli in the discharge patterns of visceral afferent fibres from the colon.

Authors:  H Blumberg; P Haupt; W Jänig; W Kohler
Journal:  Pflugers Arch       Date:  1983-06       Impact factor: 3.657

5.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

Authors:  Flobert Y Tanga; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

Review 6.  Visceral pain.

Authors:  F Cervero; J M Laird
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

7.  Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents.

Authors:  Alba Galan; J Antonio Lopez-Garcia; Fernando Cervero; Jennifer M A Laird
Journal:  Neurosci Lett       Date:  2002-03-29       Impact factor: 3.046

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

9.  Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain.

Authors:  Alba Galan; Fernando Cervero; Jennifer M A Laird
Journal:  Brain Res Mol Brain Res       Date:  2003-08-19

10.  Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.

Authors:  Burcu Tufanogullari; Paul F White; Mariana P Peixoto; Daniel Kianpour; Thomas Lacour; James Griffin; Gary Skrivanek; Amy Macaluso; Mary Shah; David A Provost
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

View more
  10 in total

1.  MicroRNA-211-5p Enhances Analgesic Effect of Dexmedetomidine on Inflammatory Visceral Pain in Rats by Suppressing ERK Signaling.

Authors:  Li Sun; Jinjun Zhou; Chaohui Sun
Journal:  J Mol Neurosci       Date:  2019-03-14       Impact factor: 3.444

2.  Nalbuphine alleviates inflammation by down-regulating NF-κB in an acute inflammatory visceral pain rat model.

Authors:  Dijiao Ruan; Yuanyuan Wang; Sisi Li; Chao Zhang; Wenwen Zheng; Cong Yu
Journal:  BMC Pharmacol Toxicol       Date:  2022-06-01       Impact factor: 2.605

3.  NF-κB-Associated Pain-Related Neuropeptide Expression in Patients with Degenerative Disc Disease.

Authors:  Aisha S Ahmed; Svante Berg; Kanar Alkass; Henrik Druid; David A Hart; Camilla I Svensson; Eva Kosek
Journal:  Int J Mol Sci       Date:  2019-02-03       Impact factor: 5.923

4.  Effects of Pre-Cardiopulmonary Bypass Administration of Dexmedetomidine on Cardiac Injuries and the Inflammatory Response in Valve Replacement Surgery With a Sevoflurane Postconditioning Protocol: A Pilot Study.

Authors:  Hongmei Zhou; Dongna Zhou; Jian Lu; Cheng Wu; Zhipeng Zhu
Journal:  J Cardiovasc Pharmacol       Date:  2019-08       Impact factor: 3.105

5.  Reconstruction Algorithm-Based Ultrasonic and Spiral CT Images in Evaluating the Effects of Dexmedetomidine Anesthesia for Acute Abdomen.

Authors:  Pinghua Tian; Shuhong Zhang; Linling Guo
Journal:  Comput Math Methods Med       Date:  2021-12-28       Impact factor: 2.238

Review 6.  Effects of Dexmedetomidine on Immune Cells: A Narrative Review.

Authors:  Rui Chen; Yan Sun; Jing Lv; Xiaoke Dou; Maosha Dai; Shujun Sun; Yun Lin
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.810

7.  Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway.

Authors:  Tianyuan Jiang; Ran Niu; Qian Liu; Yuhan Fu; Xiaoying Luo; Tao Zhang; Baoqi Wu; Juan Han; Yang Yang; Xiaolan Su; Jiande D Z Chen; Gengqing Song; Wei Wei
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

8.  Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats.

Authors:  Qian Sun; Bing-Yu Zhang; Ping-An Zhang; Ji Hu; Hong-Hong Zhang; Guang-Yin Xu
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

9.  Intravesical dexmedetomidine instillation reduces postoperative catheter-related bladder discomfort in male patients under general anesthesia: a randomized controlled study.

Authors:  Hong Chen; Bin Wang; Qin Li; Juan Zhou; Rui Li; Ye Zhang
Journal:  BMC Anesthesiol       Date:  2020-10-22       Impact factor: 2.217

Review 10.  Myocardial protective and anti-inflammatory effects of dexmedetomidine in patients undergoing cardiovascular surgery with cardiopulmonary bypass: a systematic review and meta-analysis.

Authors:  Milian Chen; Xia Li; Guo Mu
Journal:  J Anesth       Date:  2021-08-03       Impact factor: 2.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.